Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.

Nowicka AM, Kowalczyk A, Jarzebinska A, Donten M, Krysinski P, Stojek Z, Augustin E, Mazerska Z.

Biomacromolecules. 2013 Mar 11;14(3):828-33. doi: 10.1021/bm301868f. Epub 2013 Feb 1.

PMID:
23327587
2.

A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.

Gautier J, Munnier E, Paillard A, Hervé K, Douziech-Eyrolles L, Soucé M, Dubois P, Chourpa I.

Int J Pharm. 2012 Feb 14;423(1):16-25. doi: 10.1016/j.ijpharm.2011.06.010. Epub 2011 Jun 15.

PMID:
21703340
3.

Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.

Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D.

ACS Appl Mater Interfaces. 2013 May;5(9):3884-93. doi: 10.1021/am400572b. Epub 2013 Apr 23.

PMID:
23551195
4.

Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging.

Yang Y, Aw J, Chen K, Liu F, Padmanabhan P, Hou Y, Cheng Z, Xing B.

Chem Asian J. 2011 Jun 6;6(6):1381-9. doi: 10.1002/asia.201000905. Epub 2011 May 4.

PMID:
21548100
5.

Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe2O4 nanoparticles.

Oh Y, Moorthy MS, Manivasagan P, Bharathiraja S, Oh J.

Biochimie. 2017 Feb;133:7-19. doi: 10.1016/j.biochi.2016.11.012. Epub 2016 Dec 2.

PMID:
27916642
6.

Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.

Pilapong C, Keereeta Y, Munkhetkorn S, Thongtem S, Thongtem T.

Colloids Surf B Biointerfaces. 2014 Jan 1;113:249-53. doi: 10.1016/j.colsurfb.2013.09.005. Epub 2013 Sep 18.

PMID:
24103503
7.

Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.

Elbialy NS, Fathy MM, Khalil WM.

Int J Pharm. 2015 Jul 25;490(1-2):190-9. doi: 10.1016/j.ijpharm.2015.05.032. Epub 2015 May 18.

PMID:
25997662
8.

Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.

Samra ZQ, Ahmad S, Javeid M, Dar N, Aslam MS, Gull I, Ahmad MM.

Prep Biochem Biotechnol. 2013;43(8):781-97. doi: 10.1080/10826068.2013.782042.

PMID:
23876138
9.

Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.

Lee SF, Zhu XM, Wang YX, Xuan SH, You Q, Chan WH, Wong CH, Wang F, Yu JC, Cheng CH, Leung KC.

ACS Appl Mater Interfaces. 2013 Mar 13;5(5):1566-74. doi: 10.1021/am4004705. Epub 2013 Feb 25.

PMID:
23402574
10.

Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.

Taratula O, Dani RK, Schumann C, Xu H, Wang A, Song H, Dhagat P, Taratula O.

Int J Pharm. 2013 Dec 15;458(1):169-80. doi: 10.1016/j.ijpharm.2013.09.032. Epub 2013 Oct 1.

PMID:
24091153
11.

Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.

He X, Wu X, Cai X, Lin S, Xie M, Zhu X, Yan D.

Langmuir. 2012 Aug 14;28(32):11929-38. doi: 10.1021/la302546m. Epub 2012 Aug 3.

PMID:
22799877
12.

Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.

Guo M, Que C, Wang C, Liu X, Yan H, Liu K.

Biomaterials. 2011 Jan;32(1):185-94. doi: 10.1016/j.biomaterials.2010.09.077. Epub 2010 Nov 9.

PMID:
21067808
13.

Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.

Abbasi Aval N, Pirayesh Islamian J, Hatamian M, Arabfirouzjaei M, Javadpour J, Rashidi MR.

Int J Pharm. 2016 Jul 25;509(1-2):159-167. doi: 10.1016/j.ijpharm.2016.05.046. Epub 2016 May 24.

PMID:
27234695
14.

Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.

Gautier J, Allard-Vannier E, Munnier E, Soucé M, Chourpa I.

J Control Release. 2013 Jul 10;169(1-2):48-61. doi: 10.1016/j.jconrel.2013.03.018. Epub 2013 Apr 6. Review.

PMID:
23567046
15.

Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.

Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei-Zarchi S.

Chem Biol Drug Des. 2013 Sep;82(3):296-306. doi: 10.1111/cbdd.12145. Epub 2013 Jul 25.

PMID:
23594157
16.

Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.

Kang MK, Mao W, Lee JB, Yoo HS.

Int J Pharm. 2017 Mar 15;519(1-2):104-112. doi: 10.1016/j.ijpharm.2017.01.017. Epub 2017 Jan 10.

PMID:
28087384
17.

Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.

Xu SS, Wu J, Jiang W.

J Microencapsul. 2015;32(6):533-7. doi: 10.3109/02652048.2015.1065918. Epub 2015 Aug 18.

PMID:
26289219
18.

Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin.

Pourjavadi A, Hosseini SH, Alizadeh M, Bennett C.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:49-54. doi: 10.1016/j.colsurfb.2013.12.048. Epub 2013 Dec 30.

PMID:
24441180
19.

Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.

Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I.

Int J Pharm. 2008 Nov 3;363(1-2):170-6. doi: 10.1016/j.ijpharm.2008.07.006. Epub 2008 Jul 16.

PMID:
18687392
20.

Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach.

Fang C, Kievit FM, Veiseh O, Stephen ZR, Wang T, Lee D, Ellenbogen RG, Zhang M.

J Control Release. 2012 Aug 20;162(1):233-41. doi: 10.1016/j.jconrel.2012.06.028. Epub 2012 Jun 24.

Supplemental Content

Support Center